Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged 18 to 80 years old who have undergone surgery to fully remove lung cancer (known as a complete or R0 resection).
- People whose cancer was confirmed after surgery to be at stage IB, II, or IIIA, and whose cancer type was confirmed by laboratory testing to be adenocarcinoma (a specific type of lung cancer).
- People whose cancer has tested positive for a specific gene change called an EGFR mutation, specifically the type known as 19del or L858R.
- People who have received a type of targeted drug treatment after surgery called an EGFR-TKI (a medication that targets the EGFR gene mutation).
- People who have complete and clearly documented scans from before surgery, along with genetic testing results and pathology (laboratory) reports.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose cancer tested negative for the EGFR gene mutation.
- People whose surgery did not fully remove the cancer (referred to medically as R1 or R2 resection).
- People who did not receive EGFR-TKI targeted drug treatment after their surgery.
- People whose cancer has come back or has reached an advanced stage.
- People whose medical records from before or after surgery are incomplete.
- People who passed away within 30 days of having surgery.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xiaorong Dong, Dr, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phone: 02785726114
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
DFS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.